Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DLBS3233 in type-2 diabetes mellitus
NCT01472614Phase 3Completed
- Sponsor
- Dexa Medica
- Start
- Sep 2011
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DLBS3233 in type 2 diabetes mellitus (T2DM), sponsored by Dexa Medica. Started Sep 2011; status: completed.
02
Drugs
DLBS3233
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01472614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472614.